BTL Industries v. JV Medical Supplies: Default Judgment on EMSCULPT Patent Infringement
BTL Industries secured a default judgment against JV Medical Supplies for selling counterfeit EMSCULPT body-sculpting devices in violation of five asserted patents. The Indiana Southern District Court awarded $228,690 in trebled damages, a sweeping permanent injunction, and attorneys' fees — all within 323 days of filing.
BTL Industries wins default judgment over counterfeit EMSCULPT devices
On 16 November 2022, BTL Industries, Inc. filed suit against JV Medical Supplies, Inc. in the Indiana Southern District Court, asserting infringement of five patents covering its EMSCULPT electromagnetic body-sculpting device — US10478634B2, US10695575B1, USD0874009S, US10695576B2, and US11266852B2. BTL alleged that JV Medical was offering, marketing, and selling counterfeit and knock-off EMSCULPT devices through its website and social media channels.
The case terminated on 5 October 2023 on a default judgment basis, meaning JV Medical failed to appear or mount a defence. The court entered a comprehensive judgment in BTL's favour: damages were trebled to a total of $228,690, a permanent injunction was issued barring JV Medical and named individuals from any further dealing in genuine or counterfeit EMSCULPT devices, and BTL was awarded attorneys' fees and costs subject to a separate petition. The judgment also required JV Medical to disclose the identities of all suppliers and customers and to purge all references to BTL's products from its online presence.
Resolution within 323 days is consistent with the default judgment mechanism, which bypasses the discovery and trial phases entirely. The specific driver of JV Medical's non-appearance is not disclosed in the available record. The breadth of the injunctive relief — covering physical devices, online listings, and social media across multiple platforms — and the reservation of BTL's right to seek amended relief upon discovery of further sales suggest BTL's enforcement posture extends well beyond this single proceeding.
See Complete Case & Patent Analysis →Filing to Default Judgment in 323 days
323 days from filing to default judgment — resolved without defendant participation
US10478634B2 — BTL EMSCULPT electromagnetic body-sculpting device portfolio
Any company manufacturing, distributing, or importing electromagnetic body-sculpting or muscle-stimulation devices should conduct a freedom-to-operate analysis against BTL's five-patent EMSCULPT portfolio. This case demonstrates that BTL actively enforces across both functional and design dimensions, and the mandatory supply-chain disclosure obtained here means that even upstream component suppliers and downstream distributors face direct exposure — not just device manufacturers.
Official order — verbatim text
The court's default judgment order is unusually comprehensive: it combines trebled monetary damages, a named-individual permanent injunction, mandatory physical device surrender, supply-chain and customer identification obligations, and a sweeping digital take-down order across multiple social media platforms. The reservation of BTL's right to seek further relief upon discovery of additional infringing sales is notable — it keeps the judgment open-ended in scope and signals that the court treats this order as an enforcement platform rather than a final settlement of all claims.
Default judgment: what the court's ruling means for both parties
Default judgment entered after defendant failed to appear
A default judgment is entered when a defendant fails to plead or otherwise defend against a lawsuit. The court accepted BTL's well-pleaded allegations as admitted and entered final judgment under Fed. R. Civ. P. 54(b), expressly finding no just reason for delay. The judgment is binding and enforceable against JV Medical and its named officers and agents.
Defendant non-appearanceBTL secures trebled damages, injunction, and fee award
BTL Industries obtained the full range of relief: $228,690 in trebled damages, a permanent injunction prohibiting all dealings in genuine and counterfeit EMSCULPT devices, mandatory disclosure of JV Medical's supply chain and customer base, and an award of attorneys' fees and costs. BTL also reserved the right to seek further monetary or injunctive relief if additional infringing sales are discovered.
Full relief grantedJV Medical faces sweeping injunction and financial liability
JV Medical and its named personnel are permanently enjoined from any activity involving genuine or counterfeit EMSCULPT devices, required to surrender all such devices to BTL, disclose their supply chain and customers, and delete all online references to BTL's products across every digital platform. The trebled damages award and pending fee petition represent significant financial exposure for the defendant.
Permanent injunction issuedStrong enforcement signal for counterfeit aesthetics device market
The judgment signals that patent holders in the medical aesthetics device sector are prepared to pursue full default-judgment relief — including trebled damages and mandatory supply-chain disclosure — against distributors of counterfeit devices. The supply-chain identification requirement may expose upstream counterfeit manufacturers to further enforcement action. Companies operating in adjacent body-sculpting or electromagnetic therapy device markets should assess their FTO position relative to BTL's patent portfolio.
Enforcement risk elevatedFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | BTL Industries, Inc. | Company | /Search in Eureka ↗ |
| Defendant | JV Medical Supplies, Inc. | Company | /Search in Eureka ↗ |
| Plaintiff counsel | Brooke Smith | Attorney | Counsel for BTL Industries, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Kristopher N. Kazmierczak | Attorney | Counsel for BTL Industries, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Sally F. Zweig | Attorney | Counsel for BTL Industries, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Frost Brown Todd LLP | Law Firm | Representing BTL Industries, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Stoll Keenon Ogden PLLC | Law Firm | Representing BTL Industries, Inc.Search in Eureka ↗ |
| Defendant counsel | JV Medical Supplies, Inc. | Attorney | Counsel for JV Medical Supplies, Inc.Search in Eureka ↗ |
| Defendant law firm | . | Law Firm | Representing JV Medical Supplies, Inc.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Indiana Southern District CourtSearch in Eureka ↗ |
R&D signals in the electromagnetic body-sculpting device space
Forward-looking patent and innovation intelligence derived from BTL Industries' enforcement of its EMSCULPT portfolio and the broader electromagnetic muscle-stimulation technology landscape.
BTL Industries' growing EMSCULPT IP footprint
BTL's assertion of five patents — spanning utility, method, and design claims — across a single product platform suggests active, layered portfolio building in the electromagnetic muscle-stimulation space. Monitoring BTL's prosecution activity and continuation filings may reveal the direction of its next-generation device development and areas where claim coverage is expanding.
Active portfolio expansionFiling trends in high-intensity electromagnetic body contouring
High-intensity focused electromagnetic (HIFEM) technology for non-invasive body contouring is an active filing domain. Tracking global patent applications in electromagnetic muscle-stimulation and non-invasive body sculpting reveals which players — beyond BTL — are building IP positions and where white space may exist for differentiated device architectures or applicator designs.
HIFEM filing activityJV Medical's absence signals a gap in defensive IP strategy
JV Medical's failure to defend — and apparent lack of any patent counsel or law firm on record — is consistent with a distributor operating without a formal IP strategy. Companies in the medical supply distribution channel that handle aesthetic devices should assess whether they have supplier indemnification clauses and their own FTO coverage, as default judgments in this space carry trebled damages exposure.
Distributor IP riskAdjacent innovation near EMSCULPT's design and method claims
BTL's design patent (USD0874009S) protects the ornamental appearance of the EMSCULPT device, while its utility patents cover specific electromagnetic treatment methods and device configurations. Innovators developing next-generation body-sculpting devices may find white space in alternative applicator geometries, energy delivery protocols, or combination modality platforms that fall outside BTL's current claim perimeter.
Design-around opportunitySimilar patent infringement cases involving medical aesthetics devices
Explore related patent enforcement actions in the medical aesthetics and electromagnetic medical device space before the Indiana Southern District Court and comparable federal district courts.
What this case signals for the medical aesthetics device IP landscape
BTL's enforcement of five EMSCULPT patents to a full default judgment — with trebled damages and supply-chain disclosure — sets a clear template for combating counterfeit medical device distribution.
Default judgment with trebled damages is a viable enforcement tool against counterfeit sellers
BTL obtained trebled damages and a permanent injunction without reaching trial. Where a distributor of counterfeit medical devices fails to appear, patent holders can secure comprehensive relief efficiently. Companies with premium devices facing grey-market or counterfeit distribution should assess whether this approach is appropriate.
Mandatory supply-chain disclosure turns one defendant into an enforcement map
The judgment compels JV Medical to identify every supplier and customer of counterfeit EMSCULPT devices. This disclosure mechanism converts a single enforcement action into intelligence for targeting upstream manufacturers and downstream distributors — a tactic worth structuring into any future complaint in this sector.
BTL v JV — key questions answered
The Indiana Southern District Court entered a default judgment in favour of BTL Industries on 5 October 2023. JV Medical Supplies failed to appear or defend. The judgment awarded BTL trebled damages of $228,690, a permanent injunction against all dealings in genuine or counterfeit EMSCULPT devices, mandatory supply-chain and customer disclosure, and attorneys' fees and costs subject to a separate petition.
BTL asserted five patents: US10478634B2, US10695575B1, US10695576B2, and US11266852B2 (utility patents covering EMSCULPT device technology and treatment methods), and USD0874009S (a design patent covering the ornamental appearance of the EMSCULPT device). All five were asserted in the single infringement action filed in November 2022.
The court awarded trebled damages totalling $228,690 in favour of BTL. Trebling of damages in patent infringement cases is available under 35 U.S.C. § 284 where infringement is found to be wilful. However, the specific basis for the trebling determination in this default judgment is not further elaborated in the available record beyond the court's order.
The injunction prohibits JV Medical, its officers, agents, and employees from offering, marketing, importing, advertising, possessing, or distributing any BTL EMSCULPT device or any counterfeit, knock-off, or purported EMSCULPT device. It also requires deletion of all BTL-related content from JV Medical's website and social media accounts, and mandates physical surrender of all covered devices to BTL.
The court ordered JV Medical to identify by name and location every person or entity that supplied or purchased a genuine or counterfeit EMSCULPT device from JV Medical. This disclosure obligation converts the single enforcement action into an intelligence-gathering mechanism, potentially exposing upstream counterfeit manufacturers and downstream customers to further enforcement action by BTL.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.